Analytical Data
-
基因名
TEC
- Application
-
别名
PSCTK4
-
种属
Mouse
-
表达系统
E. coli
-
标签
N-His
-
纯度
Greater than 95% as determined by SDS-PAGE.
-
蛋白编号
P24604
-
表达区间
Leu369~Val622
-
分子量
33kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TEC (T-Cell Exuberant Cytokine) recombinants are a class of proteins that play a crucial role in understanding immune responses and therapeutic applications in immunology. The research background of TEC recombinant proteins stems from the need to elucidate the complex mechanisms underlying T-cell activation, differentiation, and cytokine production. T-cells are essential components of the adaptive immune system, and their dysregulation can lead to various diseases, including autoimmune disorders, infections, and cancer. By engineering recombinant forms of TEC proteins, researchers aim to dissect their functional roles and signaling pathways. These studies are empowered by advancements in molecular biology techniques, enabling the precise manipulation of protein structures and the development of novel therapeutic agents. Moreover, the therapeutic potential of TEC recombinants in enhancing vaccine efficacy or modulating immune responses highlights their significance in clinical settings. Understanding the structure-function relationships of TEC proteins may also open avenues for innovative strategies in personalized medicine, where tailored treatments can optimize immune responses for individual patients. Overall, the exploration of TEC recombinant proteins is pivotal for advancing our comprehension of immune regulation and developing cutting-edge therapies to combat immune-related diseases.












